Advancing Second-Line Treatment for Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):853-854 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38381658 Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study BMJ. 2024;384:e076388 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38350680 Challenges in the Management of Esophagogastric Varices and Variceal Hemorrhage in Cirrhosis - A Narrative Review American Journal of Medicine. 2024;137(3):210-217 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38128860 Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):795-805 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37962077 Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study Lancet. 2024;403(10427):645-656 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38278170 Factors Associated with Overlap between Functional Dyspepsia and Nonerosive Reflux Disease in Endoscopy-based Helicobacter pylori-uninfected Japanese Health Checkup Participants: A Prospective, Multicenter Cross-sectional Study Internal Medicine. 2024;63(5):639-647 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37438139 Fatal Bleeding from Aortogastric Fistula Internal Medicine. 2024;63(4):611-612 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37407457 Hepatic Amyloidosis Internal Medicine. 2024;63(4):613-614 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37344422 Liver steatosis linked to type 2 diabetes outcomes BMJ. 2024;384:q309 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38350679 Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework Journal of Internal Medicine. 2024;295(3):357-368 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37994187 Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival Journal of Internal Medicine. 2024;295(3):331-345 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37983845 Perihepatitis as an Initial Manifestation of Systemic Lupus Erythematosus Internal Medicine. 2024;63(5):739-741 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37468242 A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):783-794 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38381664 A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis New England Journal of Medicine. 2024;390(6):497-509 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38324483 Plummer-Vinson Syndrome New England Journal of Medicine. 2024;390(7):652 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38345572 PPAR Agonists in Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):855-858 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38381666 A Rare Cause of Chronic Intermittent Hematochezia American Journal of Medicine. 2024;137(3):e54-e55 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38042240 Rehabilitation Interventions in Head and Neck Cancer: A Scoping Review American Journal of Physical Medicine and Rehabilitation. 2024;103(3S Suppl 1):S62-s71 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38364033 Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019 American Journal of Medicine. 2024;137(3):258-265.e3 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38000687 Steatotic liver disease in rural and regional Victoria, according to the NAFLD and newer diagnostic criteria: retrospective cohort analyses of 2001-03 and 2016-18 data Medical Journal of Australia. 2024;220(2):97-99 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38113294 Superior Mesenteric Arteriovenous Fistula Presenting as Portal Hypertension Internal Medicine. 2024;63(5):753-754 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37407454 Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases Journal of Internal Medicine. 2024;295(3):292-312 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38212977 The value of hypersensitivity quantitative fecal immunochemical test in early colorectal cancer detection Postgraduate Medical Journal. 2024;100(1181):135-141 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38055911 Viral gastroenteritis Lancet. 2024;403(10429):862-876 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38340741 What Is Ulcerative Colitis? JAMA. 2024;331(8):716 https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38306113
Advancing Second-Line Treatment for Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):853-854
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38381658
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study BMJ. 2024;384:e076388
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38350680
Challenges in the Management of Esophagogastric Varices and Variceal Hemorrhage in Cirrhosis - A Narrative Review American Journal of Medicine. 2024;137(3):210-217
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38128860
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):795-805
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37962077
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study Lancet. 2024;403(10427):645-656
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38278170
Factors Associated with Overlap between Functional Dyspepsia and Nonerosive Reflux Disease in Endoscopy-based Helicobacter pylori-uninfected Japanese Health Checkup Participants: A Prospective, Multicenter Cross-sectional Study Internal Medicine. 2024;63(5):639-647
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37438139
Fatal Bleeding from Aortogastric Fistula Internal Medicine. 2024;63(4):611-612
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37407457
Hepatic Amyloidosis Internal Medicine. 2024;63(4):613-614
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37344422
Liver steatosis linked to type 2 diabetes outcomes BMJ. 2024;384:q309
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38350679
Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework Journal of Internal Medicine. 2024;295(3):357-368
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37994187
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival Journal of Internal Medicine. 2024;295(3):331-345
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37983845
Perihepatitis as an Initial Manifestation of Systemic Lupus Erythematosus Internal Medicine. 2024;63(5):739-741
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37468242
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):783-794
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38381664
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis New England Journal of Medicine. 2024;390(6):497-509
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38324483
Plummer-Vinson Syndrome New England Journal of Medicine. 2024;390(7):652
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38345572
PPAR Agonists in Primary Biliary Cholangitis New England Journal of Medicine. 2024;390(9):855-858
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38381666
A Rare Cause of Chronic Intermittent Hematochezia American Journal of Medicine. 2024;137(3):e54-e55
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38042240
Rehabilitation Interventions in Head and Neck Cancer: A Scoping Review American Journal of Physical Medicine and Rehabilitation. 2024;103(3S Suppl 1):S62-s71
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38364033
Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System - California, 2008-2019 American Journal of Medicine. 2024;137(3):258-265.e3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38000687
Steatotic liver disease in rural and regional Victoria, according to the NAFLD and newer diagnostic criteria: retrospective cohort analyses of 2001-03 and 2016-18 data Medical Journal of Australia. 2024;220(2):97-99
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38113294
Superior Mesenteric Arteriovenous Fistula Presenting as Portal Hypertension Internal Medicine. 2024;63(5):753-754
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37407454
Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases Journal of Internal Medicine. 2024;295(3):292-312
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38212977
The value of hypersensitivity quantitative fecal immunochemical test in early colorectal cancer detection Postgraduate Medical Journal. 2024;100(1181):135-141
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38055911
Viral gastroenteritis Lancet. 2024;403(10429):862-876
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38340741
What Is Ulcerative Colitis? JAMA. 2024;331(8):716
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38306113